Smart Girl Dumb Questions Can He Make America Healthy (and Trusting) Again? with Trump's NIH Director Jay Bhattacharya
Jan 13, 2026
Nayeema Raza welcomes Jay Bhattacharya, NIH Director and renowned physician-scientist, known for his critical views during the COVID-19 pandemic. They discuss vaccine trust post-COVID, the perplexing U.S. healthcare system, and the viability of new drugs like Ozempic. Jay highlights disparities in life expectancy, critiques health spending inefficiencies, and addresses public health mandates that fueled distrust. He also anticipates China's biotech advancements and shares optimism for breakthroughs in HIV and Alzheimer's research, emphasizing the importance of restoring trust in science.
AI Snips
Chapters
Books
Transcript
Episode notes
Message What Matters Most
- Focus public messaging on the most important vaccines, like MMR and polio, to prevent outbreaks and rebuild confidence.
- Emphasize availability and insurance coverage while explaining shared decision-making nuances.
Stalled U.S. Life Expectancy
- U.S. life expectancy has been flat since 2010 while peer nations continued to improve, raising alarm about younger generations' health.
- Rising chronic illnesses (obesity, diabetes, Alzheimer's) threaten future longevity without targeted action.
Ozempic Is Useful But Not Panacea
- GLP-1 drugs like Ozempic are a real advance but not a magic bullet for population health.
- Long-term effects, affordability, and whether metabolic improvements restore overall health remain uncertain.
